1/44
Comprehensive vocabulary flashcards covering lysosomes, proteasomal degradation, mitochondrial dynamics and bioenergetics, and chloroplast-mediated photosynthesis from the lecture notes.
Christian de Duve
The scientist credited as the founder and discoverer of the lysosome.
Acid Phosphatase
The specific hydrolytic marker enzyme used to identify and distinguish lysosomes from other organelles.
Lysosomal Optimum pH
An acidic internal environment of approximately pH=5.0, which maintains the activity of 40 to 60 hydrolytic enzymes and protects the cell from accidental self-digestion if enzymes leak into the cytoplasm at pH∼7.2.
Heterophagy
The process by which a lysosome digests extracellular materials that have been engulfed or brought inside the cell.
Elie Metchnikoff
Scientist who coined the term phagocytosis (meaning eat, cavity) and won the Nobel Prize for his contributions involving probiotics, gerontology, and the cellular basis of immunity.
Myasthenia Gravis
A neuromuscular disorder causing droopy eyelids and muscle weakness, characterized by an autoimmune response where antibodies attack acetylcholine receptors at the neuromuscular junction.
Eserine
A pharmacological agent used to treat Myasthenia Gravis by blocking acetylcholinesterase, thereby preventing the breakdown of acetylcholine.
Vyvgart
A therapeutic antibody drug composed of the Fc fragment of an IgG antibody used to manage Myasthenia Gravis.
Dan Drachman's Experiments
Studies demonstrating the autoimmune origin of Myasthenia Gravis using ^3H\text{-\alpha-bungarotoxin} to bind to acetylcholine receptors (AChR) and injecting Torpedo electroplax electric fish AChR into mice to induce disease symptoms.
Autophagy
The cellular degradation and recycling pathway targeting a cell's own damaged components and organelles, which begins at the endoplasmic reticulum and uses LC3 as a marker.
Bafilomycin A
An inhibitor that poisons the lysosomal H+ pump, raising the internal lysosomal pH from 5.0 to 7.0.
Silicosis
A non-genetic, occupational miner's disease caused by the inhalation of silica particles that disrupt lysosomes and reduce pulmonary oxygen and carbon dioxide exchange.
Genzyme Sanofi
A Massachusetts biotechnology company that pioneered Enzyme Replacement Therapy (ERT) for the treatment of lysosomal storage diseases.
Tay-Sachs Disease
A hereditary lysosomal storage disorder caused by a lack or defect in Hexosaminidase A, leading to the toxic accumulation of ganglioside GM2 primarily in the brain.
Hurler Syndrome
Mucopolysaccharidosis type I (also known as gargoylism) caused by a deficiency in α-L-iduronidase, resulting in glycosaminoglycan accumulation and treated with the enzyme replacement therapy Aldurazyme.
I-Cell Disease
A rare hereditary disorder (1 in 700,000 births) resulting from a failure to attach mannose-6-phosphate (M6P) targeting signals to acid hydrolases, causing the enzymes to be misrouted and secreted extracellularly.
Gaucher's Disease
The most common lysosomal storage disease, characterized by a glucocerebrosidase deficiency, accumulation of glucocerebroside, hepatosplenomegaly, and erosion of long bones; treated with Ceredase or Cerezyme.
Pompe Disease
A lysosomal storage disease caused by an acid α-glucosidase deficiency resulting in glycogen accumulation, managed clinically using the ERT drug Myozyme.
Proteasome
A massive, protein-degrading macromolecular complex (∼30,000 per typical cell) responsible for clearing misfolded proteins tagged by the unfolded protein response (UPR) and regulating apoptosis and the cell cycle.
Ubiquitination
The post-translational covalent modification of misfolded or target proteins with ubiquitin, serving as the required signal for recognition and degradation by the proteasome.
Bortezomib
A clinical proteasome inhibitor used to treat relapsed multiple myeloma by exacerbating endoplasmic reticulum stress and driving overloaded cancer cells into apoptosis.
Porin (VDAC)
A voltage-dependent anion channel protein situated in the outer mitochondrial membrane that forms large aqueous channels permitting the passage of molecules up to 5,000 Da.
PIGBOS
A protein located on the outer mitochondrial membrane that communicates directly with the rough endoplasmic reticulum to regulate the unfolded protein response (UPR).
Cardiolipin
A four-fatty-acid lipid found in the inner mitochondrial membrane that enhances membrane impermeability to ions, increases electrical resistance to bolster the proton motive force, and anchors the electron transport complexes together.
ER MAM (Mitochondrial-Associated Membrane)
A specialized subdomain of the endoplasmic reticulum that wraps around mitochondria to regulate calcium homeostasis, lipid metabolism, mitochondrial fission constrictions, autophagy, and mitophagy.
Tunneling Nanotubes
Intercellular conduits containing F-actin filaments that facilitate cell-to-cell transfer of mitochondria and other structures for metabolic rescue, tissue repair, and regenerative support.
MPTP (Mitochondrial Permeability Transition Pore)
A channel complex regulated by anti-apoptotic Bcl-2/Bcl-xL (closed state) and pro-apoptotic Bax/Bak oligomers (open state); opening allows Cytochrome c release into the cytoplasm under intrinsic cellular stress.
Cytochrome c
The only soluble electron carrier of the mitochondrial electron transport chain; upon release through the open MPTP, it binds to APAF-1 to trigger procaspase activation and drive apoptosis.
Cyclosporin A
An immunosuppressive compound that blocks the opening of the MPTP, mitigating intrinsic-stress-induced apoptosis to preserve stem cell viability during transport and storage.
Warburg Effect
The metabolic shift characteristic of many cancer cells, marked by the overexpression of Glut1, Glut3, PFK, and LDH, relying predominantly on aerobic glycolysis rather than mitochondrial oxidative phosphorylation.
Galactose Medium Assay
A laboratory screening method that replaces glucose with galactose in cultured hepatoma cells (HepG2) to force reliance on mitochondrial ATP generation, exposing otherwise masked drug-induced mitochondrial toxicity.
Chemiosmotic Hypothesis
The concept pioneered by Peter Mitchell proposing that an electrochemical proton gradient (ΔVm∼−200 mV) across the inner mitochondrial membrane serves as the energetic bridge driving ATP synthesis by F0F1 ATP synthase.
2,4-Dinitrophenol (DNP)
A lipid-soluble weak acid that acts as a proton ionophore, dissipating the inner mitochondrial proton gradient and uncoupling the electron transport chain from ATP synthase.
Thermogenin (UCP1)
A physiological mitochondrial uncoupling protein found in the brown fat of newborns that dissipates the proton gradient to generate heat through non-shivering thermogenesis.
Oligomycin
An antibiotic agent that directly inhibits the F0F1 ATP synthase by blocking proton translocation through the F0 subunit.
Rhodamine 123
The first vital fluorescent dye specific for mitochondria, discovered by Lan Bo Chen, which accumulates in and stains functional mitochondria proportionally to their negative inner membrane potential.
Theodor Engelmann Experiment
An experiment using the ribbon-like chloroplasts of Spirogyra illuminated with dispersed light wavelengths to demonstrate that aerotactic bacteria migrate to sites of oxygen generation illuminated by red and purple light.
Hill and van Niel Experiments
Pioneering 1930s studies using purple sulfur bacteria demonstrating that photosynthesis is a light-dependent oxidation-reduction reaction where liberated oxygen originates from water.
NeoPX (Neoplants)
A genetically engineered indoor houseplant developed in Paris designed to capture and eliminate volatile organic compounds (VOCs) from air.
Phycoerythrin
An accessory light-harvesting pigment employed by deep ocean algae that captures green light wavelengths in ocean depths depleted of red and blue light.
Resonance Energy Transfer
The non-radiative transfer of excitation energy across pigment molecules within light-harvesting antenna complexes until it reaches the reaction-center chlorophyll a, transferring energy without passing electrons.
Photoinhibition
A light-induced reduction in photosynthetic efficiency that primarily damages Photosystem II (PSII), particularly upon exposure to excess blue light.
D1 Protein
A 32,000 Da core structural protein subunit of Photosystem II that displays a high physiological turnover rate and is selectively degraded and resynthesized during photoinhibition recovery.
Rubisco
The enzyme catalyzing the initial step of carbon fixation, composed of nuclear- and chloroplast-encoded subunits; possesses low carbon dioxide affinity and can catalyze wasteful photorespiration when oxygen levels exceed carbon dioxide.
PEP Carboxylase
The primary carbon-fixing enzyme utilized by C4 plants that exhibits a high affinity for carbon dioxide, pumping concentrated CO2 into bundle sheath cells to optimize Rubisco efficiency.